• Diabetech - Diabetes Tech, News, and Management

  • By: Justin Eastzer
  • Podcast

Diabetech - Diabetes Tech, News, and Management

By: Justin Eastzer
  • Summary

  • Exploring type 1 diabetes tech, news, management, and beyond through interviews with experts, tech leaders, and those with diabetes.
    Copyright 2024 All rights reserved.
    Show more Show less
Episodes
  • The Latest Tech Innovations and Research from EASD 2024
    Sep 30 2024

    In this episode, I dive into the latest diabetes tech and research from EASD 2024. We explore everything from all-in-one CGM and pump prototypes to an exciting dual-hormone pump used by 250 people, set to launch in 2026. I also take a closer look at the Kaliedo pump and its Diabeloop algorithm. Plus, I break down new research on how the Medtronic 780G with SmartGuard can benefit kids under 7, the importance of AID systems for pregnancy, and how CGMs are keeping people with type 2 diabetes out of the hospital.

    T1D Exchange Registry Sign up (US only)

    Join our Newsletter | Diabetech Community Discord

    Support Diabetech on Patreon

    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

    Watch Next:

    Bi-Hormonal Pump from Beta Bionics

    DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

    Show more Show less
    32 mins
  • Your Endo is Tired - Navigating a Broken Healthcare System
    Sep 23 2024

    Why are so many endocrinologists burning out and leaving traditional medicine behind? Endo and artist Dr. Mike Natter shares an inside look at why many, including himself, are feeling overworked and exhausted. From grueling 70-hour work weeks to skipping meals and bathroom breaks, the pressure is relentless. Dr. Natter dives into the challenges of patient demands, endless paperwork, and the reality of being one of the lowest-paid medical specialties. We also explore why more endocrinologists are opting out of insurance and turning to concierge care and how he balances an industry focused on profits over patients, and his passion for helping people with the demands of a broken system.

    T1D Exchange Registry Sign up (US only)

    Join our Newsletter | Diabetech Community Discord

    Support Diabetech on Patreon

    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

    Follow Mike Natter

    DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

    Show more Show less
    41 mins
  • The Future of Trio: A Next-Gen Automated Insulin Delivery System
    Sep 16 2024

    Trio, a new automated insulin delivery system built by the open-source community, has officially launched as an evolution of iAPS. Trio offers improvements with a focus on safety and community feedback. I’m joined by two key admins of Trio, to discuss its future advancements, including a sleek redesign, faster performance, and expanded caregiver functions. We also touch on how users are achieving over 80% time in range without needing to bolus before meals—showcasing just how transformative this system can be.

    Find a Doctor on ZocDoc (today's sponsor)

    T1D Exchange Registry Sign up (US only)

    Join our Newsletter | Diabetech Community Discord

    Support Diabetech on Patreon

    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

    More info on Trio

    Listen: The Power of the iAPS Algorithm (still relevant!)

    DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. Trio is experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using Trio and you do so at your own risk. Results will vary.

    Show more Show less
    47 mins

What listeners say about Diabetech - Diabetes Tech, News, and Management

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.